WJCD  Vol.9 No.5 , May 2019
A Cross-Sectional Study on Assessment of Oxidative Stress in Coronary Heart Disease Patients in Bangladesh
Abstract: Oxidative stress is considered a central factor in endothelial dysfunction and plaque formation in coronary heart disease (CHD) patients. In this cross- sectional study, the stress-induced protein and lipid oxidation and production of signaling molecule, nitric oxide has been investigated in CHD patients in Bangladesh. A total of 140 participants were enrolled of which 70 were CHD patients, and the remaining 70 were control subjects having no cardiovascular disease. The diagnosis of CHD was made by expert physicians through characteristic electrocardiogram and troponin changes. The protein carbonyls and thiobarbituric acid reactive substances (TBARS) levels in plasma of both groups were measured by spectrophotometric methods. The plasma nitric oxide levels were measured by reaction with Griess reagent. Statistical non-parametric tests and t-tests were used to analyze the results between the CHD patients and controls. In the patients, the mean protein carbonyls and TBARS, two important markers of oxidative stress, were 2.87 ± 0.97 nmol/mg and 6.92 ± 3.56 nmol/mL, respectively, which were significantly higher than in the control subjects, 1.71 ± 0.82 nmol/mg and 3.15 ± 1.42 nmol/mL, respectively. Assessment of the cardiovascular signaling molecule nitric oxide showed significantly lower value in the CHD patients (6.29 ± 4.78 μM) compared to the controls (10.75 ± 6.03 μM). There was a significant negative correlation between plasma TBARS and total plasma protein, and a weak negative correlation between TBARS and nitric oxide levels in the CHD patients. Evaluation of the smoking habit strongly suggested that smoking was a risk factor for the development of CHD among the Bangladeshi population. These results provide an overview of oxidative stress-mediated damages on proteins, lipids and effects on signaling molecule nitric oxide in CHD patients.
Cite this paper: Kamruzzaman, M. , Choudhury, T. , Rahman, T. and Islam, L. (2019) A Cross-Sectional Study on Assessment of Oxidative Stress in Coronary Heart Disease Patients in Bangladesh. World Journal of Cardiovascular Diseases, 9, 331-342. doi: 10.4236/wjcd.2019.95029.

[1]   Bagatini, M.D., Martins, C.C., Battisti, V., Gasparetto, D., Da Rosa, C.S., Spanevello, R.M., Ahmed, M., Schmatz, R., Schetinger, M.R.C. and Morsch, V.M. (2011) Oxidative Stress versus Antioxidant Defenses in Patients with Acute Myocardial Infarction. Heart and Vessels, 26, 55-63.

[2]   Cross, C.E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B.N., Saul, R.L., McCord, J.M. and Harman, D. (1987) Oxygen Radicals and Human Disease. Annals of Internal Medicine, 107, 526-545.

[3]   Rodríguez, T., Malvezzi, M., Chatenoud, L., Bosetti, C., Levi, F., Negri, E. and La Vecchia, C. (2006) Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in the Americas: 1970-2000. Heart, 92, 453-460.

[4]   Sanchis-Gomar, F., Perez-Quilis, C., Leischik, R. and Lucia, A. (2016) Epidemiology of Coronary Heart Disease and Acute Coronary Syndrome. Annals of Translational Medicine, 4, 256-267.

[5]   Gaziano, T.A., Bitton, A., Anand, S., Abrahams-Gessel, S. and Murphy, A. (2010) Growing Epidemic of Coronary Heart Disease in Low-and Middle-Income Countries. Current Problems in Cardiology, 35, 72-115.

[6]   Islam, A.M. and Majumder, A.A.S. (2013) Coronary Artery Disease in Bangladesh: A Review. Indian Heart Journal, 65, 424-435.

[7]   Whiting, D.R., Guariguata, L., Weil, C. and Shaw, J. (2011) IDF Diabetes Atlas: Global Estimates of the Prevalence of Diabetes for 2011 and 2030. Diabetes Research and Clinical Practice, 94, 311-321.

[8]   Townsend, D.M., Tew, K.D. and Tapiero, H. (2003) The Importance of Glutathione in Human Disease. Biomedicine & Pharmacotherapy, 57, 145-155.

[9]   Diaz-Velez, C.R., García-CastiNeiras, S., Mendoza-Ramos, E. and Hernández-López, E. (1996) Increased Malondialdehyde in Peripheral Blood of Patients with Congestive Heart Failure. American Heart Journal, 131, 146-152.

[10]   Griffiths, H.R., Moller, L., Bartosz, G., Bast, A., Bertoni-Freddari, C., Collins, A., Cooke, M., Coolen, S., Haenen, G., Hoberg, A.M., Loft, S., et al. (2002) Biomarkers. Molecular Aspects of Medicine, 23, 101-208.

[11]   Masuda, Y. and Yamamori, Y. (1991) Histological Detection of Lipid Peroxidation Following Infusion of Tert-Butyl Hydroperoxide and ADP-Iron Complex in Perfused Rat Livers. The Japanese Journal of Pharmacology, 56, 133-142.

[12]   Naseem, K.M. (2005) The Role of Nitric Oxide in Cardiovascular Diseases. Molecular Aspects of Medicine, 26, 33-65.

[13]   Yagi, K. (1998) Simple Assay for the Level of Total Lipid Peroxides in Serum or Plasma. In: Armstrong, D., Ed., Free Radical and Antioxidant Protocols. Methods in Molecular BiologyTM, Vol. 108, Humana Press, New York.

[14]   Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.G., Ahn, B.W., Shaltiel, S. and Stadtman, E.R. (1990) Determination of Carbonyl Content in Oxidatively Modified Proteins. Methods in Enzymology, 186, 464-478.

[15]   Matough, F.A., Budin, S.B., Hamid, Z.A., Alwahaibi, N. and Mohamed, J. (2012) The Role of Oxidative Stress and Antioxidants in Diabetic Complications. Sultan Qaboos University Medical Journal, 12, 5-18.

[16]   Myint, P.K., Kwok, C.S., Luben, R.N., Wareham, N.J. and Khaw, K.T. (2014) Body Fat Percentage, Body Mass Index and Waist-to-Hip Ratio as Predictors of Mortality and Cardiovascular Disease. Heart, 100, 1613-1619.

[17]   McManus, D.D., Gore, J., Yarzebski, J., Spencer, F., Lessard, D. and Goldberg, R.J. (2011) Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI. The American Journal of Medicine, 124, 40-47.

[18]   Mons, U., Müezzinler, A., Gellert, C., SchOttker, B., Abnet, C.C., Bobak, M., de Groot, L., Freedman, N.D., Jansen, E., Kee, F. and Kromhout, D. (2015) Impact of Smoking and Smoking Cessation on Cardiovascular Events and Mortality among older Adults: Meta-Analysis of Individual Participant Data from Prospective Cohort Studies of the CHANCES Consortium. BMJ, 350, h1551.

[19]   Ozkan, Y., Ozkan, E. and Simsek, B. (2002) Plasma Total Homocysteine and Cysteine Levels as Cardiovascular Risk Factors in Coronary Heart Disease. International Journal of Cardiology, 82, 269-277.

[20]   Kumar, E.P., Mukherjee, R., Senthil, R., Parasuraman, S. and Suresh, B. (2012) Evaluation of Oxidative Stress and Antioxidant Status in Patients with Cardiovascular Disease in Rural Populations of the Nilgiris, South India. ISRN Pharmacology, 2012, Article ID: 941068.

[21]   Esterbauer, H., Schaur, R.J. and Zollner, H. (1991) Chemistry and Biochemistry of 4-Hydroxynonenal, Malonaldehyde and Related Aldehydes. Free Radical Biology and Medicine, 11, 81-128.

[22]   Beal, M.F. (2002) Oxidatively Modified Proteins in Aging and Disease. Free Radical Biology and Medicine, 32, 797-803.

[23]   Tejaswi, G., Suchitra, M.M., Rajasekhar, D., Kiranmayi, V.S. and Rao, P.S. (2017) Myeloperoxidase, Protein Carbonyls and Oxidative Stress in Coronary Artery Disease. Journal of Indian College of Cardiology, 7, 149-152.

[24]   Cannon, R.O. (1998) Role of Nitric Oxide in Cardiovascular Disease: Focus on the Endothelium. Clinical Chemistry, 44, 1809-1819.

[25]   Gürlek, A., Esenboga, K., Ozcan, OU., Cicek, OF., Ayral, P.A., Kavas, G.O and Erol, C. (2016) Serum Nitric Oxide Levels in Patients with Coronary Artery Ectasia. Anatolian Journal of Cardiology, 16, 947.